HIGHLIGHTS
- What: The aim of this study was to investigate the anticancer effect of rGO and MG-132 against ZR-75-1 and MDA-MB-231 breast cancer cell lines. The authors observed high levels of ROS, measured by DCF fluorescence intensity, in both analyzed cell lines . The authors showed a statistically of ROS characterized the ZR-75-1 line (panel A). The authors showed that rGO and MG-132 induce cytotoxic effects on breast cancer cells.
- Who: Rafał Krętowski et al. from the Department of Pharmaceutical Biochemistry, Medical University of Bialystok, Mickiewicza A, Garden . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.